(Q50711210)

18 March 2018

title

[The cost of type 2 diabetes in Spain: the CODE-2 study]. (English)

1 reference

18 March 2018

0 references

M Mata

1

1 reference

18 March 2018

F Antoñanzas

series ordinal

2

1 reference

18 March 2018

M Tafalla

series ordinal

3

1 reference

18 March 2018

P Sanz

series ordinal

4

1 reference

18 March 2018

language of work or name

Spanish

0 references

publication date

1 November 2002

1 reference

18 March 2018

published in

Gaceta Sanitaria

1 reference

18 March 2018

volume

16

1 reference

18 March 2018

issue

6

1 reference

18 March 2018

page(s)

511-520

1 reference

18 March 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

[Cost-effectiveness analysis of self-monitoring of blood glucose in type 2 diabetics].

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Diabetes mellitus and the St Vincent Declaration. The economic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Costs of type 2 diabetes in Germany. Results of the CODE-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

1 reference

7 January 2021

Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Direct medical costs for patients with type 2 diabetes in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Diabetes in Canada: direct medical costs of major macrovascular complications

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

An economic analysis of interventions for diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-9111%2802%2971973-0

7 January 2021

10.1016/S0213-9111(02)71973-0

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018